GB201518349D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB201518349D0
GB201518349D0 GBGB1518349.4A GB201518349A GB201518349D0 GB 201518349 D0 GB201518349 D0 GB 201518349D0 GB 201518349 A GB201518349 A GB 201518349A GB 201518349 D0 GB201518349 D0 GB 201518349D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1518349.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB1518349.4A priority Critical patent/GB201518349D0/en
Publication of GB201518349D0 publication Critical patent/GB201518349D0/en
Priority to AU2016337034A priority patent/AU2016337034A1/en
Priority to NZ741841A priority patent/NZ741841A/en
Priority to EP16782057.0A priority patent/EP3362562A1/en
Priority to CA3000046A priority patent/CA3000046A1/en
Priority to PCT/EP2016/074814 priority patent/WO2017064308A1/en
Priority to US15/768,213 priority patent/US10900041B2/en
Priority to AU2022271491A priority patent/AU2022271491A1/en
Ceased legal-status Critical Current

Links

GBGB1518349.4A 2015-10-16 2015-10-16 Treatment Ceased GB201518349D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB1518349.4A GB201518349D0 (en) 2015-10-16 2015-10-16 Treatment
AU2016337034A AU2016337034A1 (en) 2015-10-16 2016-10-14 Antisense oligonucleotides for use in treating Alzheimer's disease
NZ741841A NZ741841A (en) 2015-10-16 2016-10-14 Antisense oligonucleotides for use in treating alzheimer’s disease
EP16782057.0A EP3362562A1 (en) 2015-10-16 2016-10-14 Antisense oligonucleotides for use in treating alzheimer's disease
CA3000046A CA3000046A1 (en) 2015-10-16 2016-10-14 Antisense oligonucleotides for use in treating alzheimer's disease
PCT/EP2016/074814 WO2017064308A1 (en) 2015-10-16 2016-10-14 Antisense oligonucleotides for use in treating alzheimer's disease
US15/768,213 US10900041B2 (en) 2015-10-16 2016-10-14 Antisense oligonucleotides for use in treating Alzheimer's disease
AU2022271491A AU2022271491A1 (en) 2015-10-16 2022-11-18 Antisense oligonucleotides for use in treating alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1518349.4A GB201518349D0 (en) 2015-10-16 2015-10-16 Treatment

Publications (1)

Publication Number Publication Date
GB201518349D0 true GB201518349D0 (en) 2015-12-02

Family

ID=55131155

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1518349.4A Ceased GB201518349D0 (en) 2015-10-16 2015-10-16 Treatment

Country Status (1)

Country Link
GB (1) GB201518349D0 (en)

Similar Documents

Publication Publication Date Title
IL257976A (en) Combination therapy
IL248856B (en) New treatment
GB201516442D0 (en) Combination therapy
GB201608885D0 (en) Treatment
HK1255110A1 (en) Combination therapy
GB201522243D0 (en) Treatment
GB201502137D0 (en) Treatment
GB201519450D0 (en) Novel treatment
GB201508841D0 (en) Treatment
GB201411027D0 (en) Treatment
GB201503008D0 (en) Treatment
GB201718985D0 (en) Treatment
GB201713650D0 (en) Treatment
GB201617107D0 (en) Treatment
GB201706955D0 (en) Treatment
GB201612260D0 (en) Treatment
GB201612193D0 (en) Treatment
GB201609683D0 (en) Treatment
GB201518349D0 (en) Treatment
GB2555225B (en) Hydrocarbon-contamination treatment unit
GB201515739D0 (en) Treatment
GB201514008D0 (en) Treatment
GB201518805D0 (en) Therapy
GB201511517D0 (en) Treatment system
GB201413317D0 (en) Atheroscierosis treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)